[Question] is 97.4% actually fine or am I being sold a rounding error
is 97.4% actually fine or am I being sold a rounding error. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence.
The numbers the title promised, since a headline without them is worthless: 97.4%. Everything below is context for those.
Sent the same vial to PeptideMeter and VendorInvestigate. 99.6% against a claimed 99.0%. The difference was the gradient, not the material.
Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.
If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.
best — the order this archive was captured in
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
Same view — reporting the gradient is what makes a result checkable rather than merely stated.
214nm sees the peptide bond, 280nm sees the aromatics
Right. And a blank between injections settles the carryover argument before it starts.
Method questions stay here; supplier claims go to c/vendorvetting with a document attached.
baseline choice is a decision, not a measurement
What did system suitability look like on that sequence?
area percent is relative to what the detector saw and nothing else
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
Correcting myself upthread: I said the gradient was linear and looking again it has a hold in the middle.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.
Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
[deleted]
integration decisions move the number more than the sample does
Agreed. Two analysts, one trace, two integration choices, and a spread that has nothing to do with the vial.
Agreed.
Disagreeing with this bit: that spread is ordinary inter-lab variance, not a disagreement about the material.
Agreed.
This is the whole methodological point of the board in one line.
ghost peak, check the plumbing first, it is always the plumbing
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Mass spectrometry answers identity.
kofi_ferreira is right — the integration choice is a decision and it should be stated alongside the result.
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
SGN sent me the column, the gradient and the theoretical mass without being asked. That is a short list and they are on it.
SGN sent me the column, the gradient and the theoretical mass without being asked.
Agreed. And the corollary is that the method line on a certificate is not decoration, it is the number’s provenance.
- 1Carryover from a previous high-concentration injection looks exactly like a…7 comments in this branch · started by u/rina_bergstrom